Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
14.81Price to Book
VS
Market
Sector
Industry
History
$ 2.5Close
$ 1.36 - $ 2.99 52-Week Range
Ticker Information
Ticker
IMMXCompany Name
IMMIX BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQIMMIX BIOPHARMA INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
IMMX - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 4.65M | $ 68.91M | 14.81 |
| 3/31/2025 | $ 9.59M | $ 59.8M | 6.23 |
| 12/31/2024 | $ 13.25M | $ 51.29M | 3.87 |
| 9/30/2024 | $ 17.55M | $ 47.31M | 2.7 |
| 6/30/2024 | $ 23.89M | $ 50.78M | 2.13 |
| 3/31/2024 | $ 27.92M | $ 57.58M | 2.06 |
| 12/31/2023 | $ 16.41M | $ 81.04M | 4.94 |
| 9/30/2023 | $ 19.77M | $ 84.44M | 4.27 |
| 6/30/2023 | $ 13.23M | $ 29.64M | 2.24 |
| 3/31/2023 | $ 11.77M | $ 32.02M | 2.72 |
Key Performance Insights, Last 5 Years
- IMMIX BIOPHARMA INC's latest trailing twelve months (TTM) P/B stands at 0.
- Over the past 5 years, IMMIX BIOPHARMA INC's average P/B has been 3.54.
- The median P/B for IMMIX BIOPHARMA INC during this period was 2.24
- IMMIX BIOPHARMA INC reached its highest P/B over the past 5 years at 14.81.
- The lowest P/B recorded by IMMIX BIOPHARMA INC in the same timeframe 0.65
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for IMMIX BIOPHARMA INC is calculated as follows: Market Cap [ $ 0 ] / Equity [ $ -4.73M ]
(=) P/B [ 0 ] IMMX - Price to Book, Last 5 years
0.65
Minimum
Sep 30, 2022
14.81
Maximum
Jun 30, 2025
3.54
Average
2.24
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |